These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17121896)

  • 21. Comparison of biochemical and biological effects of ML858 (salinosporamide A) and bortezomib.
    Williamson MJ; Blank JL; Bruzzese FJ; Cao Y; Daniels JS; Dick LR; Labutti J; Mazzola AM; Patil AD; Reimer CL; Solomon MS; Stirling M; Tian Y; Tsu CA; Weatherhead GS; Zhang JX; Rolfe M
    Mol Cancer Ther; 2006 Dec; 5(12):3052-61. PubMed ID: 17172407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacodynamic and efficacy studies of the novel proteasome inhibitor NPI-0052 (marizomib) in a human plasmacytoma xenograft murine model.
    Singh AV; Palladino MA; Lloyd GK; Potts BC; Chauhan D; Anderson KC
    Br J Haematol; 2010 May; 149(4):550-9. PubMed ID: 20331453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel proteasome inhibitor NPI-0052 as an anticancer therapy.
    Chauhan D; Hideshima T; Anderson KC
    Br J Cancer; 2006 Oct; 95(8):961-5. PubMed ID: 17047643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacterial self-resistance to the natural proteasome inhibitor salinosporamide A.
    Kale AJ; McGlinchey RP; Lechner A; Moore BS
    ACS Chem Biol; 2011 Nov; 6(11):1257-64. PubMed ID: 21882868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysing properties of proteasome inhibitors using kinetic and X-ray crystallographic studies.
    Gallastegui N; Groll M
    Methods Mol Biol; 2012; 832():373-90. PubMed ID: 22350899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stabilization effect of resin on the production of potent proteasome inhibitor NPI-0052 during submerged fermentation of Salinispora tropica.
    Tsueng G; Lam KS
    J Antibiot (Tokyo); 2007 Jul; 60(7):469-72. PubMed ID: 17721007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting ubiquitin in cancers.
    Dikic I; Crosetto N; Calatroni S; Bernasconi P
    Eur J Cancer; 2006 Dec; 42(18):3095-102. PubMed ID: 17084074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salinosporamide A: a highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus salinospora.
    Feling RH; Buchanan GO; Mincer TJ; Kauffman CA; Jensen PR; Fenical W
    Angew Chem Int Ed Engl; 2003 Jan; 42(3):355-7. PubMed ID: 12548698
    [No Abstract]   [Full Text] [Related]  

  • 29. Proteasome regulator marizomib (NPI-0052) exhibits prolonged inhibition, attenuated efflux, and greater cytotoxicity than its reversible analogs.
    Obaidat A; Weiss J; Wahlgren B; Manam RR; Macherla VR; McArthur K; Chao TH; Palladino MA; Lloyd GK; Potts BC; Enna SJ; Neuteboom ST; Hagenbuch B
    J Pharmacol Exp Ther; 2011 May; 337(2):479-86. PubMed ID: 21303921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A concise and straightforward total synthesis of (+/-)-salinosporamide A, based on a biosynthesis model.
    Mulholland NP; Pattenden G; Walters IA
    Org Biomol Chem; 2008 Aug; 6(15):2782-9. PubMed ID: 18633536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiprotealide is a natural product.
    Manam RR; Macherla VR; Tsueng G; Dring CW; Weiss J; Neuteboom ST; Lam KS; Potts BC
    J Nat Prod; 2009 Feb; 72(2):295-7. PubMed ID: 19133779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. I.V. Administration of L-GNRH-PE66 efficiently inhibits growth of colon adenocarcinoma xenografts in nude mice.
    Ben-Yehudah A; Prus D; Lorberboum-Galski H
    Int J Cancer; 2001 Apr; 92(2):263-8. PubMed ID: 11291055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NPI-0052 and γ-radiation induce a synergistic apoptotic effect in medulloblastoma.
    Frisira E; Rashid F; Varma SN; Badodi S; Benjamin-Ombo VA; Michod D; Niklison-Chirou MV
    Cell Death Dis; 2019 Oct; 10(11):785. PubMed ID: 31619667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of indomethacin as an antitumor agent in Colon 26-bearing conventional and nude mice, and telomerase activity in the tumors.
    Ogino M; Hisatomi H; Hanazono M
    Exp Anim; 1999 Jan; 48(1):15-21. PubMed ID: 10067201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salinosporamide natural products: Potent 20 S proteasome inhibitors as promising cancer chemotherapeutics.
    Gulder TA; Moore BS
    Angew Chem Int Ed Engl; 2010 Dec; 49(49):9346-67. PubMed ID: 20927786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced folates and fluoropyrimidine antitumor efficacy.
    Houghton JA; Houghton PJ
    Cancer Treat Res; 1989; 42():23-43. PubMed ID: 2577105
    [No Abstract]   [Full Text] [Related]  

  • 37. Generating a generation of proteasome inhibitors: from microbial fermentation to total synthesis of salinosporamide a (marizomib) and other salinosporamides.
    Potts BC; Lam KS
    Mar Drugs; 2010 Mar; 8(4):835-80. PubMed ID: 20479958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new antimitotic substance, FR182877. II. The mechanism of action.
    Sato B; Nakajima H; Hori Y; Hino M; Hashimoto S; Terano H
    J Antibiot (Tokyo); 2000 Feb; 53(2):204-6. PubMed ID: 10805584
    [No Abstract]   [Full Text] [Related]  

  • 39. Discovery and development of the anticancer agent salinosporamide A (NPI-0052).
    Fenical W; Jensen PR; Palladino MA; Lam KS; Lloyd GK; Potts BC
    Bioorg Med Chem; 2009 Mar; 17(6):2175-80. PubMed ID: 19022674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmaceutical Agents for Targeting Autophagy and Their Applications in Clinics.
    Kench U; Sologova S; Smolyarchuk E; Prassolov V; Spirin P
    Pharmaceuticals (Basel); 2024 Oct; 17(10):. PubMed ID: 39458996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.